Stock to Watch!

PPHM – Peregrine Pharmaceuticals

PPHM – Peregrine Pharmaceuticals is a biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment of cancer and viral infections. Its products under development include bavituximab, which is in Phase II trials for the treatment of lung cancer and pancreatic cancer. The company is also developing ribavirin, which is in Phase II clinical trial for the treatment of patients with genotype-1 hepatitis C virus infections, liver cancer, prostate cancer and breast cancer.

Peregrine Pharma – PPHM – also provides contract manufacturing of antibodies, recombinant proteins, and enzymes; cell culture development; process development; and testing for biopharmaceutical and biotechnology companies. The company has licensing agreements with the University of Texas Southwestern Medical Center, Merck and SuperGen.

Great potential, Undervalued, Bouncing back from 52WK LOWS!

Don’t miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.